A Phase Ii Trial of Dovitinib in Bcg-Unresponsive Urothelial Carcinoma with Fgfr3 Mutations or Overexpression: Hoosier Cancer Research Network Trial Hcrn 12-157 Noah M. Hahn , Trinity J. Bivalacqua , Ashley E. Ross , George J. Netto , Alex Baras , Jong Chul Park , Carolyn Chapman , Timothy A. Masterson , Michael O. Koch , Richard Bihrle , Richard S. Foster , Thomas A. Gardner , Liang Cheng , David R. Jones , Kyle McElyea , George E. Sandusky , Timothy Breen , Ziyue Liu , Costantine Albany , Marietta L. Moore , Rhoda L. Loman , Angela Reed , Scott A. Turner , Francine B. De Abreu , Torrey Gallagher , Gregory J. Tsongalis , Elizabeth R. Plimack , Richard E. Greenberg , Daniel M. Geynisman CLINICAL CANCER RESEARCH（2017）
AI 理解论文
溯源树
样例
